Literature DB >> 1505983

Assignment of the human glycogen debrancher gene to chromosome 1p21.

T L Yang-Feng1, K Zheng, J Yu, B Z Yang, Y T Chen, F T Kao.   

Abstract

Glycogen debranching enzyme is a monomeric protein containing two independent catalytic activities of glycantransferase and glucosidase that are both required for glycogen degradation. Its deficiency causes type III glycogen storage disease. A majority of the patients with this disease have deficient enzyme activity in both liver and muscle (type IIIa) but approximately 15% of them lack enzyme activity only in the liver (type IIIb); however, the enzyme is a monomer and appears to be identical in all the tissues. The cDNA coding for the complete human muscle debranching enzyme has recently been isolated. Using the cDNA clones, the debrancher gene was localized to human chromosome 1 by somatic cell hybrid analysis. Regional assignment to chromosome band 1p21 was determined by in situ hybridization. Mapping of the debrancher gene to a single chromosome site is consistent with our hypotheses that a single gene encodes both liver and muscle debrancher protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505983     DOI: 10.1016/0888-7543(92)90003-b

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III.

Authors:  T Fukuda; H Sugie; M Ito
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId.

Authors:  H Sugie; T Fukuda; M Ito; Y Sugie; T Kojoh; I Nonaka
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

3.  Polymorphic markers of the glycogen debranching enzyme gene allowing linkage analysis in families with glycogen storage disease type III.

Authors:  J Shen; H M Liu; Y Bao; Y T Chen
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

4.  Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.

Authors:  Christiaan P Sentner; Yvonne J Vos; Klary N Niezen-Koning; Bart Mol; G Peter A Smit
Journal:  JIMD Rep       Date:  2012-03-16

5.  RFLPs for linkage analysis in families with glycogen storage disease type III.

Authors:  A Mishori-Dery; N Bashan; S Moses; E Hershkovitz; Y Bao; Y T Chen; R Parvari
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.

Authors:  Chaoxia Lu; Zhengqing Qiu; Miao Sun; Wei Wang; Min Wei; Xue Zhang
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

7.  Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases.

Authors:  Claire-Cécile Michon; Marcela Gargiulo; Valérie Hahn-Barma; François Petit; Aleksandra Nadaj-Pakleza; Ariane Herson; Bruno Eymard; Philippe Labrune; Pascal Laforet
Journal:  J Inherit Metab Dis       Date:  2014-11-12       Impact factor: 4.982

8.  Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.

Authors:  J Shen; Y Bao; H M Liu; P Lee; J V Leonard; Y T Chen
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

9.  Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency.

Authors:  S Lucchiari; D Santoro; S Pagliarani; G P Comi
Journal:  Acta Myol       Date:  2007-07

10.  Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.

Authors:  Shawyntee M Vertilus; Stephanie L Austin; Kimberly S Foster; Keri E Boyette; Deeksha S Bali; Jennifer S Li; Priya S Kishnani; Stephanie Burns Wechsler
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.